Assignee
PURDUE PHARMA
CA·7 granted patents·3 pending applications·112 citations·filing 2000–2018
Top patents by PatentIndex Score
10 records- 0196US10111839B2Methods and compositions particularly for treatment of attention deficit disorderPURDUE PHARMA·Filed 2018·Granted Oct 30, 2018·12 cites·28 claims
- 0294US9801823B2Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrationsPURDUE PHARMA·Filed 2015·Granted Oct 31, 2017·13 cites·12 claims
- 0394US7438930B2Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrationsPURDUE PHARMA·Filed 2007·Granted Oct 21, 2008·21 cites·11 claims
- 0493US9974752B2Methods and compositions particularly for treatment of attention deficit disorderPURDUE PHARMA·Filed 2015·Granted May 22, 2018·11 cites·30 claims
- 0593US9066869B2Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrationsPURDUE PHARMA·Filed 2013·Granted Jun 30, 2015·13 cites·20 claims
- 0690US7247318B2Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrationsPURDUE PHARMA·Filed 2002·Granted Jul 24, 2007·24 cites·12 claims
- 0785US7060293B1Powder-layered oral dosage formsPURDUE PHARMA·Filed 2000·Granted Jun 13, 2006·18 cites·17 claims
- 0850US2019224130A1Pharmaceutical compositions comprising hydromorphone and naloxonePURDUE PHARMA·Filed 2018·Application pending·0 cites
- 0950US2015283091A1Pharmaceutical compositions comprising hydromorphone and naloxonePURDUE PHARMA·Filed 2013·Application pending·0 cites
- 1033US2017182031A1Reducing drug liking in a subjectPURDUE PHARMA·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →